Journal
NEUROSCIENCE LETTERS
Volume 468, Issue 1, Pages 56-58Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2009.10.062
Keywords
Parkinson's disease; Interleukin-6; Physical performance; Sarcopenia
Categories
Funding
- Rede Instituto Brasileiro de Neurocincia
- Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig), Brazi
Ask authors/readers for more resources
Some studies have demonstrated altered circulating levels of cytokines, including IL-6, in Parkinson's disease (PD), implying a possible involvement of inflammatory and immune-mediated mechanisms in its pathogenesis. Moreover, the increased production of inflammatory cytokines has been associated with cognitive impairment and poor physical performance in the elderly. We compared serum levels of IL-6 in 44 PD patients and 22 healthy subjects, and correlated them with PD specific instruments and functional tests. Serum levels of IL-6 were significantly increased in PD (p = 0.015). There was no correlation between serum levels of IL-6 and instruments traditionally used to assess PD severity. However, we found that PD patients with higher serum levels of IL-6 spent more time at functional mobility tests and had lower gait speed. Also, these patients had major problems to keep balance during functional tasks that required postural changes and that had a reduced base support. These results showed that high levels of IL-6 can be involved with an acceleration of muscle catabolism leading to sarcopenia, therefore contributing to weakness and fatigue, and may also be associated with functional disability in PD. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available